vs
通用电气医疗（OPCH）与Rivian Automotive, Inc.（RIVN）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Rivian Automotive, Inc.的1.1倍（$1.4B vs $1.3B），通用电气医疗净利率更高（3.6% vs -63.1%，领先66.7%），通用电气医疗同比增速更快（12.2% vs -25.8%），通用电气医疗自由现金流更多（$130.2M vs $-1.1B），过去两年通用电气医疗的营收复合增速更高（13.0% vs 3.3%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
Rivian Automotive是2009年成立的美国电动汽车制造商及汽车科技企业，主打基于自研滑板平台打造的电动SUV、皮卡及EDV电动配送货车，旗下R1T皮卡于2021年末正式开启交付，还计划于2023年底前在美国和加拿大布局专属充电网络，其平台可适配新车型也可对外授权使用。
OPCH vs RIVN — 直观对比
营收规模更大
OPCH
是对方的1.1倍
$1.3B
营收增速更快
OPCH
高出38.1%
-25.8%
净利率更高
OPCH
高出66.7%
-63.1%
自由现金流更多
OPCH
多$1.3B
$-1.1B
两年增速更快
OPCH
近两年复合增速
3.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.3B |
| 净利润 | $51.8M | $-811.0M |
| 毛利率 | 19.0% | 9.3% |
| 营业利润率 | 5.9% | -64.8% |
| 净利率 | 3.6% | -63.1% |
| 营收同比 | 12.2% | -25.8% |
| 净利润同比 | -3.8% | -9.0% |
| 每股收益（稀释后） | $0.32 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPCHRIVN
| Q4 25 | — | $1.3B | ||
| Q3 25 | $1.4B | $1.6B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.3B | $1.2B | ||
| Q4 24 | $1.3B | $1.7B | ||
| Q3 24 | $1.3B | $874.0M | ||
| Q2 24 | $1.2B | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
净利润OPCHRIVN
| Q4 25 | — | $-811.0M | ||
| Q3 25 | $51.8M | $-1.2B | ||
| Q2 25 | $50.5M | $-1.1B | ||
| Q1 25 | $46.7M | $-545.0M | ||
| Q4 24 | $60.1M | $-744.0M | ||
| Q3 24 | $53.9M | $-1.1B | ||
| Q2 24 | $53.0M | $-1.5B | ||
| Q1 24 | $44.8M | $-1.4B |
毛利率OPCHRIVN
| Q4 25 | — | 9.3% | ||
| Q3 25 | 19.0% | 1.5% | ||
| Q2 25 | 19.0% | -15.8% | ||
| Q1 25 | 19.7% | 16.6% | ||
| Q4 24 | 21.3% | 9.8% | ||
| Q3 24 | 20.1% | -44.9% | ||
| Q2 24 | 20.3% | -38.9% | ||
| Q1 24 | 20.8% | -43.8% |
营业利润率OPCHRIVN
| Q4 25 | — | -64.8% | ||
| Q3 25 | 5.9% | -63.1% | ||
| Q2 25 | 5.8% | -85.5% | ||
| Q1 25 | 5.9% | -52.8% | ||
| Q4 24 | 6.9% | -38.1% | ||
| Q3 24 | 6.7% | -133.8% | ||
| Q2 24 | 6.6% | -118.7% | ||
| Q1 24 | 6.0% | -123.3% |
净利率OPCHRIVN
| Q4 25 | — | -63.1% | ||
| Q3 25 | 3.6% | -75.3% | ||
| Q2 25 | 3.6% | -85.7% | ||
| Q1 25 | 3.5% | -44.0% | ||
| Q4 24 | 4.8% | -42.9% | ||
| Q3 24 | 4.2% | -125.9% | ||
| Q2 24 | 4.3% | -125.8% | ||
| Q1 24 | 3.9% | -120.1% |
每股收益（稀释后）OPCHRIVN
| Q4 25 | — | $-0.66 | ||
| Q3 25 | $0.32 | $-0.96 | ||
| Q2 25 | $0.31 | $-0.97 | ||
| Q1 25 | $0.28 | $-0.48 | ||
| Q4 24 | $0.36 | $-0.67 | ||
| Q3 24 | $0.31 | $-1.08 | ||
| Q2 24 | $0.30 | $-1.46 | ||
| Q1 24 | $0.26 | $-1.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $309.8M | $6.1B |
| 总债务越低越好 | $1.2B | — |
| 股东权益账面价值 | $1.4B | $4.6B |
| 总资产 | $3.5B | $14.9B |
| 负债/权益比越低杠杆越低 | 0.86× | — |
8季度趋势，按日历期对齐
现金及短期投资OPCHRIVN
| Q4 25 | — | $6.1B | ||
| Q3 25 | $309.8M | $7.1B | ||
| Q2 25 | $198.8M | $7.5B | ||
| Q1 25 | $171.4M | $7.2B | ||
| Q4 24 | $412.6M | $7.7B | ||
| Q3 24 | $483.0M | $6.7B | ||
| Q2 24 | $376.9M | $7.9B | ||
| Q1 24 | $219.5M | $7.9B |
总债务OPCHRIVN
| Q4 25 | — | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | $5.5B | ||
| Q1 24 | $1.1B | $4.4B |
股东权益OPCHRIVN
| Q4 25 | — | $4.6B | ||
| Q3 25 | $1.4B | $5.1B | ||
| Q2 25 | $1.4B | $6.1B | ||
| Q1 25 | $1.4B | $6.2B | ||
| Q4 24 | $1.4B | $6.6B | ||
| Q3 24 | $1.4B | $5.9B | ||
| Q2 24 | $1.4B | $6.8B | ||
| Q1 24 | $1.4B | $8.1B |
总资产OPCHRIVN
| Q4 25 | — | $14.9B | ||
| Q3 25 | $3.5B | $15.2B | ||
| Q2 25 | $3.4B | $15.6B | ||
| Q1 25 | $3.3B | $15.5B | ||
| Q4 24 | $3.4B | $15.4B | ||
| Q3 24 | $3.4B | $14.3B | ||
| Q2 24 | $3.3B | $15.4B | ||
| Q1 24 | $3.2B | $15.7B |
负债/权益比OPCHRIVN
| Q4 25 | — | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.79× | 0.81× | ||
| Q1 24 | 0.74× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $139.4M | $-681.0M |
| 自由现金流经营现金流 - 资本支出 | $130.2M | $-1.1B |
| 自由现金流率自由现金流/营收 | 9.1% | -89.0% |
| 资本支出强度资本支出/营收 | 0.6% | 36.0% |
| 现金转化率经营现金流/净利润 | 2.69× | — |
| 过去12个月自由现金流最近4个季度 | $220.7M | $-2.5B |
8季度趋势，按日历期对齐
经营现金流OPCHRIVN
| Q4 25 | — | $-681.0M | ||
| Q3 25 | $139.4M | $26.0M | ||
| Q2 25 | $90.3M | $64.0M | ||
| Q1 25 | $-7.2M | $-188.0M | ||
| Q4 24 | $36.1M | $1.2B | ||
| Q3 24 | $160.4M | $-876.0M | ||
| Q2 24 | $195.7M | $-754.0M | ||
| Q1 24 | $-68.8M | $-1.3B |
自由现金流OPCHRIVN
| Q4 25 | — | $-1.1B | ||
| Q3 25 | $130.2M | $-421.0M | ||
| Q2 25 | $81.2M | $-398.0M | ||
| Q1 25 | $-16.6M | $-526.0M | ||
| Q4 24 | $25.8M | $856.0M | ||
| Q3 24 | $150.7M | $-1.2B | ||
| Q2 24 | $185.9M | $-1.0B | ||
| Q1 24 | $-74.6M | $-1.5B |
自由现金流率OPCHRIVN
| Q4 25 | — | -89.0% | ||
| Q3 25 | 9.1% | -27.0% | ||
| Q2 25 | 5.7% | -30.5% | ||
| Q1 25 | -1.2% | -42.4% | ||
| Q4 24 | 2.0% | 49.4% | ||
| Q3 24 | 11.8% | -131.9% | ||
| Q2 24 | 15.1% | -89.6% | ||
| Q1 24 | -6.5% | -126.5% |
资本支出强度OPCHRIVN
| Q4 25 | — | 36.0% | ||
| Q3 25 | 0.6% | 28.7% | ||
| Q2 25 | 0.6% | 35.5% | ||
| Q1 25 | 0.7% | 27.3% | ||
| Q4 24 | 0.8% | 18.9% | ||
| Q3 24 | 0.8% | 31.7% | ||
| Q2 24 | 0.8% | 24.4% | ||
| Q1 24 | 0.5% | 21.1% |
现金转化率OPCHRIVN
| Q4 25 | — | — | ||
| Q3 25 | 2.69× | — | ||
| Q2 25 | 1.79× | — | ||
| Q1 25 | -0.15× | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | 2.98× | — | ||
| Q2 24 | 3.69× | — | ||
| Q1 24 | -1.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
RIVN
| Automotive Segment | $839.0M | 65% |
| Software And Services Segment | $447.0M | 35% |
| Regulatory Credits | $30.0M | 2% |
